FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Journal / Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cell...
;

Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.

Abstract: Degenerative joint disease is one of the main causes of equine early retirement from pleasure riding or a performance career. The disease is initially triggered by an abnormal loading of normal cartilage or a normal loading of abnormal cartilage. This primary insult is accompanied with joint inflammation, which leads to further progressive degeneration of the articular cartilage and changes in the surrounding tissues. Therefore, in search for an effective treatment, 75 adult horses with early signs of degenerative fetlock joint disease were enrolled in a randomized, multicenter, double-blinded, and placebo-controlled study. Fifty animals were injected intra-articularly with the investigational veterinary product (IVP) consisting of allogeneic chondrogenic induced mesenchymal stem cells (ciMSCs) with equine allogeneic plasma, and 25 horses were injected with 0.9% NaCl (saline) control product. From week 3 to 18 after treatment, lameness scores (P < 0.001), flexion test responses (P < 0.034), and joint effusion scores (P < 0.001) were remarkably superior in IVP-treated horses. Besides nasal discharge in both treatment groups, no adverse events were observed during the entire study period. On long-term follow-up (1 year), significantly more investigational product-treated horses were working at training level or were returned to their previous level of work (P < 0.001).
Get Full Text
Publication Date: PubMed ID: 30623737
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates how a treatment involving the injection of stem cells can help in treating early signs of Degenerative Joint Disease (DJD) in horses. The study results demonstrate a significant improvement in the condition of horses treated with this method when compared to a control group.

Research Context and Aim

  • Degenerative Joint Disease (DJD) is a significant cause for early retirement in horses, often affecting their performance and pleasure riding abilities. This disease is primarily triggered by abnormal or extreme stress exerted on the cartilage.
  • Given the need for effective treatments, the researchers conducted a randomized, multicenter, double-blinded, and placebo-controlled study involving 75 adult horses showing early signs of DJD.

Research Method

  • Of the total of 75 horses, 50 were treated with an injection of allogeneic chondrogenic induced mesenchymal stem cells (ciMSCs) combined with equine allogeneic plasma. This experimental veterinary product aimed to regenerate damaged cartilage, improving the condition of the joint. This experimental group is referred to as the “IVP-treated horses” in the study.
  • The remaining 25 horses were injected with a saline solution as a control group.
  • Several aspects such as lameness scores, flexion test responses, and joint effusion scores were recorded and analysed from week 3 to week 18 after the treatment.

Research Findings

  • Compared to the control group, IVP-treated horses showed significant improvement in the aforementioned aspects. For instance, scores for lameness, flexion test responses, and joint effusion were notably better in IVP-treated horses.
  • The study noted no adverse events in both groups, except for nasal discharge. This indicates that the treatment was well-tolerated by the animals.
  • In a longer-term follow-up (1 year), substantially more horses treated with the stem cell product were able to return to their prior level of work or were working at training level. Thus, the treatment was not only effective in the short-term but also in the long run.

Conclusions

  • The findings suggest that the use of mesenchymal stem cells can be an effective strategy for treating DJD in horses.
  • However, further research may be required to explore the full potential of this treatment strategy, understand its effects in greater detail, and investigate potential risks or side effects associated with repeated or long-term use.

Cite This Article

APA
(). Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. .

Publication

Researcher Affiliations

Citations

This article has been cited 33 times.
  1. Gaesser AM, Cianci JM, Even K, Linardi RL, Ruthel G, Barot D, Elkhenany H, Engiles JB, Ortved KF. Equine Bone Marrow-Derived MSCs and Their EVs Exhibit Different Immunomodulatory Effects on Cartilage Explants in an In Vitro Osteoarthritis Model. Cartilage 2025 Sep 25;:19476035251378693.
    doi: 10.1177/19476035251378693pubmed: 40995888google scholar: lookup
  2. Luque RM, Henderson B, McCorkell TC, Alizadeh AH, Russell KA, Koch TG, Koenig J. Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid. Equine Vet J 2025 Sep;57(5):1245-1254.
    doi: 10.1111/evj.14531pubmed: 40364589google scholar: lookup
  3. Seabaugh K, Rao S, Koenig JB, Pezzanite L, Dow S, Koch TG, Russell KA, Mehrpouyan S, Alizadeh AH, Goodrich LR. A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in Horses. Animals (Basel) 2024 Nov 26;14(23).
    doi: 10.3390/ani14233406pubmed: 39682372google scholar: lookup
  4. Berni P, Andreoli V, Conti V, Ramoni R, Basini G, Scattini G, Pascucci L, Pellegrini M, Del Bue M, Squassino GP, Paino F, Pessina A, Alessandri G, Pirazzoli P, Bosetto A, Grolli S. Evaluation of a Novel Mechanical Device for the Production of Microfragmented Adipose Tissue for Veterinary Regenerative Medicine: A Proof-of-Concept. Int J Mol Sci 2024 Nov 4;25(21).
    doi: 10.3390/ijms252111854pubmed: 39519405google scholar: lookup
  5. Reis IL, Lopes B, Sousa P, Sousa AC, Caseiro AR, Mendonça CM, Santos JM, Atayde LM, Alvites RD, Maurício AC. Equine Musculoskeletal Pathologies: Clinical Approaches and Therapeutical Perspectives-A Review. Vet Sci 2024 Apr 26;11(5).
    doi: 10.3390/vetsci11050190pubmed: 38787162google scholar: lookup
  6. de Oliveira AT, Braga ARF, Miranda JRF, Fantinato-Neto P, Ambrósio CE. Mesenchymal stem cells in animal reproduction: sources, uses and scenario. Braz J Vet Med 2024;46:e002524.
    doi: 10.29374/2527-2179.bjvm002524pubmed: 38737577google scholar: lookup
  7. Moellerberndt J, Niebert S, Fey K, Hagen A, Burk J. Impact of platelet lysate on immunoregulatory characteristics of equine mesenchymal stromal cells. Front Vet Sci 2024;11:1385395.
    doi: 10.3389/fvets.2024.1385395pubmed: 38725585google scholar: lookup
  8. Andersen C, Walters M, Bundgaard L, Berg LC, Vonk LA, Lundgren-Åkerlund E, Henriksen BL, Lindegaard C, Skovgaard K, Jacobsen S. Intraarticular treatment with integrin α10β1-selected mesenchymal stem cells affects microRNA expression in experimental post-traumatic osteoarthritis in horses. Front Vet Sci 2024;11:1374681.
    doi: 10.3389/fvets.2024.1374681pubmed: 38596460google scholar: lookup
  9. Velot É, Balmayor ER, Bertoni L, Chubinskaya S, Cicuttini F, de Girolamo L, Demoor M, Grigolo B, Jones E, Kon E, Lisignoli G, Murphy M, Noël D, Vinatier C, van Osch GJVM, Cucchiarini M. Women's contribution to stem cell research for osteoarthritis: an opinion paper. Front Cell Dev Biol 2023;11:1209047.
    doi: 10.3389/fcell.2023.1209047pubmed: 38174070google scholar: lookup
  10. Andersen C, Jacobsen S, Uvebrant K, Griffin JF 4th, Vonk LA, Walters M, Berg LC, Lundgren-Åkerlund E, Lindegaard C. Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model. Cartilage 2025 Jun;16(2):250-264.
    doi: 10.1177/19476035231209402pubmed: 37990503google scholar: lookup
  11. Everett JB, Menarim BC, Barrett SH, Bogers SH, Byron CR, Pleasant RS, Werre SR, Dahlgren LA. Intra-articular bone marrow mononuclear cell therapy improves lameness from naturally occurring equine osteoarthritis. Front Vet Sci 2023;10:1256284.
    doi: 10.3389/fvets.2023.1256284pubmed: 37876630google scholar: lookup
  12. O'Brien TJ, Hollinshead F, Goodrich LR. Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?. Extracell Vesicles Circ Nucl Acids 2023 Jun;4(2):151-169.
    doi: 10.20517/evcna.2023.11pubmed: 37829144google scholar: lookup
  13. Baouche M, Ochota M, Locatelli Y, Mermillod P, Niżański W. Mesenchymal Stem Cells: Generalities and Clinical Significance in Feline and Canine Medicine. Animals (Basel) 2023 Jun 7;13(12).
    doi: 10.3390/ani13121903pubmed: 37370414google scholar: lookup
  14. Leal Reis I, Lopes B, Sousa P, Sousa AC, Branquinho M, Caseiro AR, Pedrosa SS, Rêma A, Oliveira C, Porto B, Atayde L, Amorim I, Alvites R, Santos JM, Maurício AC. Allogenic Synovia-Derived Mesenchymal Stem Cells for Treatment of Equine Tendinopathies and Desmopathies-Proof of Concept. Animals (Basel) 2023 Apr 11;13(8).
    doi: 10.3390/ani13081312pubmed: 37106875google scholar: lookup
  15. Mayet A, Zablotski Y, Roth SP, Brehm W, Troillet A. Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis. Front Vet Sci 2023;10:1125695.
    doi: 10.3389/fvets.2023.1125695pubmed: 36908512google scholar: lookup
  16. Liu L, Qiu L, Zhu Y, Luo L, Han X, Man M, Li F, Ren M, Xing Y. Comparisons between Plant and Animal Stem Cells Regarding Regeneration Potential and Application. Int J Mol Sci 2023 Feb 23;24(5).
    doi: 10.3390/ijms24054392pubmed: 36901821google scholar: lookup
  17. Zhu Y, Fu W. Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review. Front Bioeng Biotechnol 2022;10:956614.
    doi: 10.3389/fbioe.2022.956614pubmed: 35935493google scholar: lookup
  18. Kearney CM, Khatab S, van Buul GM, Plomp SGM, Korthagen NM, Labberté MC, Goodrich LR, Kisiday JD, Van Weeren PR, van Osch GJVM, Brama PAJ. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation. Front Vet Sci 2022;9:907616.
    doi: 10.3389/fvets.2022.907616pubmed: 35812845google scholar: lookup
  19. Roth SP, Burk J, Brehm W, Troillet A. MSC in Tendon and Joint Disease: The Context-Sensitive Link Between Targets and Therapeutic Mechanisms. Front Bioeng Biotechnol 2022;10:855095.
    doi: 10.3389/fbioe.2022.855095pubmed: 35445006google scholar: lookup
  20. Hagen A, Holland H, Brandt VP, Doll CU, Häußler TC, Melzer M, Moellerberndt J, Lehmann H, Burk J. Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same. Animals (Basel) 2022 Jan 13;12(2).
    doi: 10.3390/ani12020189pubmed: 35049811google scholar: lookup
  21. Mund SJK, MacPhee DJ, Campbell J, Honaramooz A, Wobeser B, Barber SM. Macroscopic, Histologic, and Immunomodulatory Response of Limb Wounds Following Intravenous Allogeneic Cord Blood-Derived Multipotent Mesenchymal Stromal Cell Therapy in Horses. Cells 2021 Nov 1;10(11).
    doi: 10.3390/cells10112972pubmed: 34831196google scholar: lookup
  22. Hotham WE, Thompson C, Szu-Ting L, Henson FMD. The anti-inflammatory effects of equine bone marrow stem cell-derived extracellular vesicles on autologous chondrocytes. Vet Rec Open 2021 Dec;8(1):e22.
    doi: 10.1002/vro2.22pubmed: 34795904google scholar: lookup
  23. Prządka P, Buczak K, Frejlich E, Gąsior L, Suliga K, Kiełbowicz Z. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders. Biomolecules 2021 Aug 2;11(8).
    doi: 10.3390/biom11081141pubmed: 34439807google scholar: lookup
  24. Zayed M, Adair S, Dhar M. Effects of Normal Synovial Fluid and Interferon Gamma on Chondrogenic Capability and Immunomodulatory Potential Respectively on Equine Mesenchymal Stem Cells. Int J Mol Sci 2021 Jun 15;22(12).
    doi: 10.3390/ijms22126391pubmed: 34203758google scholar: lookup
  25. Ganiev I, Alexandrova N, Aimaletdinov A, Rutland C, Malanyeva A, Rizvanov A, Zakirova E. The treatment of articular cartilage injuries with mesenchymal stem cells in different animal species. Open Vet J 2021 Jan-Mar;11(1):128-134.
    doi: 10.4314/ovj.v11i1.19pubmed: 33898294google scholar: lookup
  26. Bertoni L, Jacquet-Guibon S, Branly T, Desancé M, Legendre F, Melin M, Rivory P, Hartmann DJ, Schmutz A, Denoix JM, Demoor M, Audigié F, Galéra P. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model. Int J Mol Sci 2021 Mar 2;22(5).
    doi: 10.3390/ijms22052499pubmed: 33801461google scholar: lookup
  27. Hagen A, Lehmann H, Aurich S, Bauer N, Melzer M, Moellerberndt J, Patané V, Schnabel CL, Burk J. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture. Front Bioeng Biotechnol 2020;8:613621.
    doi: 10.3389/fbioe.2020.613621pubmed: 33553119google scholar: lookup
  28. Kamm JL, Riley CB, Parlane N, Gee EK, McIlwraith CW. Interactions Between Allogeneic Mesenchymal Stromal Cells and the Recipient Immune System: A Comparative Review With Relevance to Equine Outcomes. Front Vet Sci 2020;7:617647.
    doi: 10.3389/fvets.2020.617647pubmed: 33521090google scholar: lookup
  29. Kim KH, Park TS, Cho BW, Kim TM. Nanoparticles from Equine Fetal Bone Marrow-Derived Cells Enhance the Survival of Injured Chondrocytes. Animals (Basel) 2020 Sep 23;10(10).
    doi: 10.3390/ani10101723pubmed: 32977476google scholar: lookup
  30. Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?. Cells 2020 Jun 11;9(6).
    doi: 10.3390/cells9061453pubmed: 32545382google scholar: lookup
  31. Chen YR, Yan X, Yuan FZ, Ye J, Xu BB, Zhou ZX, Mao ZM, Guan J, Song YF, Sun ZW, Wang XJ, Chen ZY, Wang DY, Fan BS, Yang M, Song ST, Jiang D, Yu JK. The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration In Vivo: A Review. Front Pharmacol 2020;11:404.
    doi: 10.3389/fphar.2020.00404pubmed: 32308625google scholar: lookup
  32. Magri C, Schramme M, Febre M, Cauvin E, Labadie F, Saulnier N, François I, Lechartier A, Aebischer D, Moncelet AS, Maddens S. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study. PLoS One 2019;14(8):e0221317.
    doi: 10.1371/journal.pone.0221317pubmed: 31465445google scholar: lookup
  33. Gugjoo MB, Fazili MR, Gayas MA, Ahmad RA, Dhama K. Animal mesenchymal stem cell research in cartilage regenerative medicine - a review. Vet Q 2019 Dec;39(1):95-120.
    doi: 10.1080/01652176.2019.1643051pubmed: 31291836google scholar: lookup
Subscribe to our newsletter
Join 99,308 horse owners like you who receive our email updates on horse health and nutrition.